Genicular artery embolization is emerging as a minimally invasive option for chronic knee pain, potentially filling the gap between conservative treatments and major surgery.
By Adam Makins·
For decades, patients with chronic knee pain have faced a frustrating choice: endure the discomfort of conservative treatments or undergo major joint replacement surgery. Now, a minimally invasive procedure called genicular artery embolization (GAE) is changing that calculus.
Cynthia Schraf-Fletcher, 74, describes the experience simply: “life-changing.” Nearly a year after the outpatient procedure on her right knee, she reports results comparable to the total knee replacement she had on her left side, but without the complications and lengthy recovery. Gardening, cycling, and daily activities that once brought substantial pain now feel manageable.
The science behind genicular artery embolization is elegantly straightforward. The procedure reduces blood flow to inflamed areas inside the knee by releasing tiny beads into abnormal blood vessels. By calming inflammation, the treatment reduces swelling and pain without replacing the joint or making large surgical incisions.
The entire procedure typically takes one to two hours under conscious sedation, meaning patients are comfortable but awake. An interventional radiologist makes a small incision in the leg crease, threads a catheter through the femoral artery using X-ray guidance, and navigates to the genicular arteries around the knee. Once there, the team deploys the therapeutic beads to targeted problem areas.
Recovery happens fast. Patients go home the same day and are usually back to light activity within days. Compare that to the months of rehabilitation following traditional knee replacement surgery.
Dr. Leigh Casadaban, an interventional radiologist at the University of Colorado Anschutz School of Medicine, captures the procedure’s significance plainly: “For treating osteoarthritis in the knees, we often think of medications, physical therapy, maybe a steroid injection, and then on the far end of the spectrum is a total knee replacement. There really hasn’t been anything for patients in between.”
That gap represents millions of people. Osteoarthritis affects countless individuals annually, gradually breaking down cartilage and causing pain, stiffness, and reduced mobility. Those with mild to moderate knee osteoarthritis appear to be the best candidates, though patients with more advanced disease can also benefit, though perhaps for shorter durations.
The results are impressive. According to Casadaban, about 70% of patients experience phenomenal outcomes, cutting their pain scores in half or more. Some report no pain at all. For people who have exhausted conservative options but fear major surgery, that’s genuinely transformative.
Recent research has produced genuinely encouraging data. Four-year studies from Japan demonstrate that a single outpatient procedure can provide pain relief lasting those full four years. U.S. data now shows two-year relief outcomes for responders. That durability suggests GAE might actually be modifying something fundamental about joint inflammation, not merely masking symptoms temporarily.
The FDA has granted “breakthrough device status” to several GAE-related technologies since 2021, acknowledging the treatment’s potential to meaningfully improve patient outcomes. This designation helps accelerate development and review of these promising technologies.
Casadaban is leading clinical trials at CU Anschutz to better understand what happens inside the knee after GAE. One study examines fluid changes in the joint, hoping to uncover the mechanisms behind inflammation reduction. Another evaluates a temporary treatment device called Nexsphere-F that blocks small blood vessels contributing to pain and swelling.
These investigations matter because understanding the mechanism could unlock applications beyond the knee. Researchers are already exploring similar approaches for frozen shoulder, tennis elbow, and plantar fasciitis. If ongoing studies continue demonstrating lasting benefits, GAE could become standard care for anyone hesitating between ineffective conservative treatments and invasive surgery.
The science of pain management is evolving, and genicular artery embolization represents a genuinely innovative middle path for millions struggling with chronic knee problems who thought surgery was their only escape.
Materials provided by University of Colorado Anschutz School of Medicine. Original written by Kara Mason.
